Navigation Links
Researchers at Axial Biotech Develop a DNA Test for Scoliosis
Date:9/11/2008

believe that the use of DNA-based testing to determine the likelihood of disease progression will initiate a new era of improvements in spine health," says Jim Ogilvie, M.D, Chief Medical Consultant. "From a clinical standpoint, this test delivers the promise of personalized medicine to spine surgeons who will now have the opportunity to determine the likely disease progression for an individual AIS patient, and can make evidence-based recommendations for patient-specific treatment options."

Geneticists at Axial Biotech are currently analyzing the data from the 9,000 patients studied, to identify genetic factors that initially cause this disease, and the company anticipates that soon it may largely understand the specific biology for this aggressive and crippling disease, and hopes to develop molecular treatments for scoliosis patients.

The AIS prognostic test will be marketed under the trade name of ScoliScore(TM) and will be marketed and distributed by DePuy Spine, a Johnson & Johnson company.

About Axial Biotech

Axial Biotech, Inc. develops molecular diagnostic assays and motion preservation technologies for common spinal diseases and disorders. Axial has developed the first DNA-based prognostic test for Adolescent Idiopathic Scoliosis. Axial is accredited by the College of American Pathologists (CAP) and is certified to comply with the Clinical Laboratory Improvement Amendments (CLIA). Founded in 2002, Axial is based in Salt Lake City, Utah.


'/>"/>
SOURCE Axial Biotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
2. Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
3. Dallas Researchers Find Compression Stockings Improperly Used
4. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
5. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
6. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
7. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
8. NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
9. Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
10. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
11. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
(Date:11/6/2009)...NexBio Inc., in collaboration with scientists at t...), St. Louis University, and the University of Hon...icles in the peer-reviewed journal PLoS ONE. Thes...se ® ) may play a potentially important role ...nfluenza A(H1N1) and drug-resistant influenza. ,...
(Date:11/6/2009)... -- , - Trial Will Compare NXL103 With Le...lti-Resistant Staphylococcus Aureus (MRSA) Infecti...l company focused on the discovery and,development...nificant global,problem of microbial resistance, a...terial NXL103 (flopristin/linopristin), has starte...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Exploring standards to advance microbial genomics 9201 1Exploring standards to advance microbial genomics 9201 2Exploring standards to advance microbial genomics 9201 3Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 1Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 2Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 3Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal 28R 29 Vet a New Chemotherapeutic Agent for Dogs 51323 4China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 1China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 2
...s; 11 Breast Cancer Studies; 9 Targeted,Agent Stud...all/ -- Lilly,Oncology will unveil 76 studies at t...Clinical Oncology (ASCO) in Chicago, Ill. from,Jun...ta on,GEMZAR(R) (gemcitabine HCl for injection), A...in, an investigational, oral, targeted,therapy. Th...
...ia--(BUSINESS WIRE)--May 23, 2007 -,ProtoKinetix I...studies conducted by ITTEC Stem, Inc. at the Unive...AAGP(TM) in the cryopreservation,process for stem ...ecule in the rapidly expanding stem cell industry....on human embryonic stem cells., Using standard cry...
Other Medicine Technology:Making Science Personal: Lilly Oncology to Unveil 76 Studies at,ASCO 2007 2ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2
(Date:11/8/2009)...he battle is won," said Dr. Charmaine Yoest. ,... a vote of 240-194, the Stupak-Ellsworth-Pitts-Kap...t abortion mandates and funding in HR 3962 passed ...e Action President and CEO Dr. Charmaine Yoest sai... the pro-life Americans across this country who ha...
(Date:11/8/2009)...e-USNewswire/ -- The following was released today ...recta Nex. ,, Mr. Terry and his associates fro...ild-killing by abortion out of any health care bil...reat first step to victory -- a touchdown in the f...d of us. Our rejoicing must be tempered by reality...
(Date:11/7/2009)...e-USNewswire/ -- Karen Ignagni, President and CEO ...ed the following statement today on House passage ... comprehensive health care reform, and we have con...e overhaul of how health insurance is provided. Ea...elimination of pre-existing condition exclusions, ...
(Date:11/7/2009)...-- Calling this a "defining moment" for the Americ... James Rohack, M.D., today addressed medical stude...al specialty societies at the opening of the AMA,s...ystem reform will top the agenda. ,, (Logo: h...O ) ,, "Over the next 72 hours, this AMA Hous...
(Date:11/7/2009)...e-USNewswire/ -- Speaker Nancy Pelosi and Democrat...n following a Democratic Whip meeting with Preside... Speaker,s opening remarks: ,, "Thank you very... us to receive the President of the United States ...r vote and making progress for the American people...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...ity of implanted cardiac pacemakers and defibrilla... devices still tended to malfunction// at times. ...the pacemaker or the defibrillator reliability of ...a malfunctioning heart. Dr. William H. Maise...
... Nanaimo, B.C. man, George Cook father Cheryle Coo... be launched against the hospital. His death was m...treatment. It took seven hours before he was seen ...r's home to Nanaimo Regional General Hospital suff...
...ealed that women aged 60 and younger have an incre...tack compared to others. The results of the study ...th-care costs of such patients when compared to he...e. According to lead author Dr. Susmita Mallik...
... organization has undertaken a campaign to elimina... at the sixth International Multidisciplinary Cong...nital Infection and Neoplasia (EUROGIN) held in Pa... Government is a non-profit, bi-partisan organizat...
...a novel way to verify that the complete cancer has...ed report is published in the May issue of Radiolo...xplored region of the electromagnetic spectrum--th...ogy has the potential to eliminate the need for mu...
... survey it was found that pet owners are the main ...f human obesity pet obesity have propped up. //Acc...imals could cause as much suffering as those that ...oner about the number of obese pets that visited t...
Other Medicine News:Health News:Reliability of Pacemakers and Defibrillators to be Improved 2Health News:Depression Accompanies Heart Attacks in Younger Women 2Health News:Campaign to Eliminate Cervical Cancer 2Health News:Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments 2
Chagatest ELISA
...with recombinant technology, that have been fully ...ble of detecting the different types of T.cruzi th...o acid sequences repeated in tandem. SAPA (shed ac... of the infection, it reacts with 93% of the patie...
T. cruzi IgG CELISA
Chagas Quick Step
Medicine Products: